We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.05B
AUM Growth
+$276M
Cap. Flow
+$75.9M
Cap. Flow %
1.08%
Top 10 Hldgs %
27.96%
Holding
1,430
New
433
Increased
334
Reduced
305
Closed
319

Top Buys

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$182M
2
ENDP
Endo International plc
ENDP
+$170M
3
AET
Aetna Inc
AET
+$131M
4
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$108M
5
BKD icon
Brookdale Senior Living
BKD
+$91.4M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$435M
2
ELV icon
Elevance Health
ELV
+$121M
3
CI icon
Cigna
CI
+$119M
4
WMGI
Wright Medical Group Inc
WMGI
+$82.7M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$72.8M

Sector Composition

Rank Sector Weight
1 Healthcare 51.65%
2 Financials 7.93%
3 Consumer Discretionary 7.5%
4 Technology 6.5%
5 Industrials 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTI icon
1126
British American Tobacco
BTI
$122B
– –
-6,844
Closed -$355K
BWXT icon
1127
BWX Technologies
BWXT
$13.4B
– –
-11,676
Closed -$268K
CADE
1128
DELISTED
Cadence Bank
CADE
– –
-126,376
Closed -$2.93M
CAG icon
1129
Conagra Brands
CAG
$7.21B
– –
-17,265
Closed -$491K
CBOE icon
1130
Cboe Global Markets
CBOE
$28.2B
– –
-10,095
Closed -$580K
CBRE icon
1131
CBRE Group
CBRE
$40.6B
– –
-8,901
Closed -$345K
CBRL icon
1132
Cracker Barrel
CBRL
$1.01B
– –
-5,765
Closed -$877K
CCJ icon
1133
Cameco
CCJ
$39.7B
– –
-301,000
Closed -$4.75M
CDNS icon
1134
Cadence Design Systems
CDNS
$75.4B
– –
-140,400
Closed -$2.59M
CE icon
1135
Celanese
CE
$5.18B
– –
-17,092
Closed -$955K
CFG icon
1136
Citizens Financial Group
CFG
$29.6B
– –
-251,582
Closed -$6.07M
CFR icon
1137
Cullen/Frost Bankers
CFR
$10.1B
– –
-8,802
Closed -$608K
CHE icon
1138
Chemed
CHE
$6.62B
– –
-2,029
Closed -$242K
CHRW icon
1139
C.H. Robinson
CHRW
$18.4B
– –
-4,169
Closed -$305K
CI icon
1140
Cigna
CI
$76.3B
– –
-921,123
Closed -$119M
CLDX icon
1141
Celldex Therapeutics
CLDX
$3.02B
– –
-1,160
Closed -$485K
CLS icon
1142
Celestica
CLS
$40B
– –
-12,300
Closed -$137K
CMCSA icon
1143
Comcast
CMCSA
$86.7B
– –
-22,600
Closed -$638K
CMS icon
1144
CMS Energy
CMS
$20.7B
– –
-123,678
Closed -$4.32M
CNA icon
1145
CNA Financial
CNA
$13.1B
– –
-56,200
Closed -$2.33M
CNQ icon
1146
Canadian Natural Resources
CNQ
$106B
– –
-206,855
Closed -$3.07M
CP icon
1147
Canadian Pacific Kansas City
CP
$78.3B
– –
-512,500
Closed -$18.7M
CRL icon
1148
Charles River Laboratories
CRL
$13B
– –
-4,705
Closed -$373K
CVX icon
1149
Chevron
CVX
$427B
– –
-17,332
Closed -$1.82M
CYD icon
1150
China Yuchai International
CYD
$1.27B
– –
-10,600
Closed -$209K
44 45
46
47 48

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q2 2015 Portfolio in Review

As of Q2 2015, Visium Asset Management held 1,430 positions worth $7.05B, up 4.1% from $6.78B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Visium Asset Management's Q2 2015 filing shows 433 new, 334 increased, 305 reduced and 319 closed positions. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M. The largest sale was Allergan plc, an estimated $435M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 53% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Visium Asset Management's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M.
  • Visium Asset Management added most to Bausch Health in Q2 2015, an estimated $182M increase.
  • Visium Asset Management's biggest Q2 2015 reduction was Elevance Health, cutting an estimated $121M.
  • Visium Asset Management fully exited Allergan plc in Q2 2015, selling an estimated $435M.
  • Visium Asset Management's ten largest holdings make up 28% of its $7.05B portfolio in Q2 2015.
  • Visium Asset Management opened 433 new positions and closed 319 in Q2 2015.
  • Visium Asset Management's portfolio value rose 4.1% quarter-over-quarter to $7.05B.

Based on Visium Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.